The landscape of dementia analysis has advanced substantially with the appearance of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent checks that will detect Alzheimer's pathology yrs before indicators arise. While these technological developments characterize outstanding progress in knowledge neurodegenerative ill